Interspecies differences with in vitro and in vivo models of vascular tissue engineering
Source abstract
Abstract
In arterial replacement there is a clear clinical need for a functional substitute possessing appropriate haemocompatible properties to be implanted as small diameter artery. Endothelial cell seeding constitutes an appreciated method to improve blood compatibility on the condition that cells firmly adhere to the support. Along this way, an innovative technique based on multilayered polyelectrolyte films (PEM) as cell adhesive substrate was previously validated in vitro and in vivo in a small-animal model. In this study, we extended the work on a larger animal (sheep) to validate furthermore the paradigm of PEM functionalization for vascular substitutes. We tested in vitro: the efficiency of PEM to induce endothelial progenitor differentiation in sheep endothelial cells; the ability of PEM to sustain cell proliferation and allow resistance to shear stress; the fate of PEM-coated de-endothelialized human saphenous veins under flow conditions, a prerequisite step before in vivo experiments. Despite in vitro differences we were encouraged by testing in vivo PEM-coated prosthesis as carotid replacement in sheep, but without success. In order to explain the implantation failure, an in vitro haemocompatibility evaluation was performed that highlighted interspecies differences able to explain, at least in part, the graft failure obtained.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Peripheral Artery Disease Management · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. Are animal models as good as we think?10.1016/j.theriogenology.2007.09.030 ↗
2. Prosthetic vascular grafts: wrong models, wrong questions and no healing10.1016/j.biomaterials.2007.07.017 ↗
3. Inter-society consensus for the management of peripheral arterial disease (TASC II)10.1016/j.ejvs.2006.09.024 ↗
4. The evolution of vascular tissue engineering and current state of the art10.1159/000331406 ↗
5. Endothelial cell transplantation
6. Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization – a review of current strategies10.1016/j.biotechadv.2009.10.005 ↗
7. Endothelial cell–interactions with polyelectrolyte multilayer films10.1016/j.biomaterials.2004.11.036 ↗
8. Endothelial cells grown on thin polyelectrolyte mutlilayered films: an evaluation of a new versatile surface modification10.1016/S0142-9612(03)00214-X ↗
9. Poly(styrenesulfonate)/poly(allylamine) multilayers: a route to favor endothelial cell growth on expanded poly(tetrafluoroethylene) vascular grafts10.1021/bm070348n ↗
10. Polyelectrolyte multilayer film and human mesenchymal stem cells: an attractive alternative in vascular engineering applications10.1002/jbm.a.32981 ↗
11. Re-endothelialization of human umbilical arteries treated with polyelectrolyte multilayers: a tool for damaged vessel replacement10.1002/adfm.200600795 ↗
12. Denatured venous homograft as an arterial substitute in civilian vascular injuries. Thirty months' experience10.1016/S1078-5884(98)80104-4 ↗
13. A comparison between PTFE and denatured homologous vein grafts for haemodialysis access: a prospective randomised multicentre trial. The SMASH Study Group. Study of Graft Materials in Access for Haemodialysis10.1016/S1078-5884(98)80153-6 ↗
14. Small vessel replacement by human umbilical arteries with polyelectrolyte film-treated arteries: in vivo behavior10.1016/j.jacc.2008.08.009 ↗
15. Polyelectrolyte films boost progenitor cell differentiation into endothelium-like monolayers10.1002/adma.200702418 ↗
16. Human progenitor-derived endothelial cells vs. venous endothelial cells for vascular tissue engineering: an in vitro study
17. Whatever their differentiation status, human progenitor derived – or mature – endothelial cells induce osteoblastic differentiation of bone marrow stromal cells10.1002/term.1539 ↗
18. Cultivation of endothelial progenitor cells on fibrin matrix and layering on Dacron/polytetrafluoroethylene vascular grafts10.1111/j.1525-1594.2006.00211.x ↗
19. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo10.1038/nm0901-1035 ↗
20. Endothelial cells cultured on engineered vascular grafts are able to transduce shear stress10.1089/ten.2006.12.1 ↗
21. Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury10.1186/1465-9921-8-50 ↗
22. The effect of RGD density on osteoblast and endothelial cell behavior on RGD-grafted polyethylene terephthalate surfaces10.1016/j.biomaterials.2008.10.033 ↗
23. Unusual transduction response of progenitor-derived and mature endothelial cells exposed to laminar pulsatile shear stress10.1016/j.jbiomech.2008.06.003 ↗
24. In vitro characterization of a compliant biodegradable scaffold with a novel bioreactor system10.1007/s10439-007-9304-z ↗
25. Layer-by-layer deposition of polyelectrolytes–a versatile tool for the in vivo repair of blood vessels10.1002/anie.200301708 ↗
26. Nanocoatings onto arteries via layer-by-layer deposition: toward the in vivo repair of damaged blood vessels10.1021/ja034321x ↗
27. Polyelectrolyte multilayer films allow seeded human progenitor-derived endothelial cells to remain functional under shear stress in vitro10.1016/j.actbio.2009.11.012 ↗
28. Endothelialized and preconditioned natural umbilical arteries with long term patency open the route for future human uses10.3233/CH-131728 ↗
29. Polyelectrolyte multilayer films: from physico-chemical properties to the control of cellular processes10.2174/092986708783885219 ↗
30. Cold-stored venous allografts in the treatment of critical limb ischaemia10.1016/j.ejvs.2007.04.005 ↗
31. Animal models for the assessment of novel vascular conduits10.1016/j.jvs.2009.10.080 ↗
32. Human tissue-engineered blood vessels for adult arterial revascularization10.1038/nm1364 ↗
33. Compliance properties of conduits used in vascular reconstruction10.1046/j.1365-2168.2000.01566.x ↗
34. Comparison of the ovine and porcine animal models for biocompatibility testing of vascular prostheses10.1016/j.jss.2004.10.021 ↗
35. Stentless bioprosthetic heart valve research: sheep versus primate model10.1016/S0003-4975(01)02502-4 ↗
36. Tissue engineered vascular grafts – preclinical aspects10.1016/j.ijcard.2012.09.069 ↗
37. Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model10.1016/j.biomaterials.2013.04.059 ↗
38. 3-D surface charges modulate protrusive and contractile contacts of chondrosarcoma cells10.1002/cm.10140 ↗
39. Decellularized umbilical artery treated with thin polyelectrolyte multilayer films: potential use in vascular engineering
40. Flow effects on coagulation and thrombosis10.1161/01.ATV.0000229658.76797.30 ↗
41. Validating animal models for preclinical research: a scientific and ethical discussion10.1177/026119291003800309 ↗
42. Interspecies differences in coagulation profile10.1160/TH08-02-0103 ↗
43. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes10.1016/j.biomaterials.2004.01.023 ↗
44. Nonthrombogenic approaches to cardiovascular bioengineering10.1146/annurev-bioeng-071910-124733 ↗
45. Haemocompatibility testing of biomaterials using human platelets10.3233/CH-2012-1579 ↗
46. Synthesis and antithrombogenicity of heparinized polyurethanes with intervening spacer chains of various kinds10.1016/0142-9612(91)90007-W ↗
47. Platelet adhesion onto chargeable functional group gradient surfaces10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H ↗
48. Experimental carotid stenosis and endothelial injury in the rabbit: an in vivo model to study intravascular platelet aggregation10.1055/s-0038-1648436 ↗